User profiles for D. Kia
Danial Sharifi KiaAlign Technology, Inc. Verified email at pitt.edu Cited by 238 |
Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences
C Manzoni, DA Kia, J Vandrovcova… - Briefings in …, 2018 - academic.oup.com
Advances in the technologies and informatics used to generate and process large biological
data sets (omics data) are promoting a critical shift in the study of biomedical sciences. …
data sets (omics data) are promoting a critical shift in the study of biomedical sciences. …
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
…, S Bandres-Ciga, D Chang, M Tan, DA Kia… - The Lancet …, 2019 - thelancet.com
Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …
the scope of biological knowledge about the disease over the past decade. We aimed to …
Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography
J Arnaud, I Fortis, S Blachier, D Kia, A Favier - Journal of Chromatography B …, 1991 - Elsevier
A simultaneous determination of retinol, α-tocopherol and β-carotene in serum by high-performance
liquid chromatography is desdribed. Total analysis time is 13 min. A reversed-phase …
liquid chromatography is desdribed. Total analysis time is 13 min. A reversed-phase …
Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …
has led to the discovery of an increasing number of loci shown reliably to be associated …
[HTML][HTML] Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study
AJ Noyce, DA Kia, G Hemani, A Nicolas, TR Price… - PLoS …, 2017 - journals.plos.org
… Association France Parkinson, the French programme “Investissements d’avenir” funding
(ANR-10-… Amouyel) for allowing us to use part of the 3C cohort, and D. Zelenika for support in …
(ANR-10-… Amouyel) for allowing us to use part of the 3C cohort, and D. Zelenika for support in …
[HTML][HTML] Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome
CS Storm, DA Kia, MM Almramhi… - Nature …, 2021 - nature.com
Parkinson’s disease is a neurodegenerative movement disorder that currently has no
disease-modifying treatment, partly owing to inefficiencies in drug target identification and …
disease-modifying treatment, partly owing to inefficiencies in drug target identification and …
Expanding Parkinson's disease genetics: novel risk loci, genomic context, causal insights and heritable risk
…, K Heilbron, S Bandres-Ciga, D Chang, M Tan, DA Kia… - BioRxiv, 2019 - biorxiv.org
We performed the largest genome-wide association study of PD to date, involving the
analysis of 7.8M SNPs in 37.7K cases, 18.6K UK Biobank proxy-cases, and 1.4M controls. We …
analysis of 7.8M SNPs in 37.7K cases, 18.6K UK Biobank proxy-cases, and 1.4M controls. We …
On the contact behavior of micro-/nano-structured interface used in vertical-contact-mode triboelectric nanogenerators
… of D. In all the simulation cases, we first increase the value of D from minimum to the maximum
indentation depth to simulate the approach process, and then we decrease the value of D …
indentation depth to simulate the approach process, and then we decrease the value of D …
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
…, R Kaiyrzhanov, B Middlehurst, DA Kia… - Movement …, 2019 - Wiley Online Library
Background PD is a complex polygenic disorder. In recent years, several genes from the
endocytic membrane‐trafficking pathway have been suggested to contribute to disease etiology…
endocytic membrane‐trafficking pathway have been suggested to contribute to disease etiology…
Frequency of loss of function variants in LRRK2 in Parkinson disease
C Blauwendraat, X Reed, DA Kia, Z Gan-Or… - JAMA …, 2018 - jamanetwork.com
Importance Pathogenic variants inLRRK2are a relatively common genetic cause of Parkinson
disease (PD). Currently, the molecular mechanism underlying disease is unknown, and …
disease (PD). Currently, the molecular mechanism underlying disease is unknown, and …